Northwestern University
Chicago, Illinois, 60611, United States
NCT Number: NCT05308017
The purpose of this study is to compare two different types of scopes that can be used for HoLEP. HoLEP is performed through the urethra using a Laser scope to remove obstructing prostate tissue. Laser scopes come in different sizes (diameters).
Looking for future studies?
Notify Me18 year–89 year
Male
Interventional
Not applicable
Chicago, Illinois, 60611, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
24F Laser with HoLEP
28 F Laser with HoLEP
Time frame: Day 0
comparing operative time between the 24F and the 28F laser scope groups.
Time frame: Day 0
Internal survey within REDCap to be completed by the surgeon using the scope. The survey will ask the surgeon the following questions after every surgery
a. 1) Poor 2) Problematic 3) Mediocre 4) Adequate 5) Good
Time frame: Day 0
Internal survey within REDCap to be completed by the surgeon using the scope. The survey will ask the surgeon the following questions after every surgery
a. 1) Poor 2) Problematic 3) Mediocre 4) Adequate 5) Good
Time frame: Day 0
Internal survey within REDCap to be completed by the surgeon using the scope. The survey will ask the surgeon the following questions after every surgery
a. 1) Yes 2) No
Northwestern University
Other
Does Sheath Size Matter? Wolf 24 F vs. Storz 28 F Laser Sheath Size for Holmium Laser Enucleation of the Prostate
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03423979
Benign Prostatic Hyperplasia, Benign Prostatic Hypertrophy
Santiago de los Caballeros, Santiago Province, Dominican Republic
View Trial DetailsNCT05082142
Benign Prostatic Hypertrophy, Calculi
Chicago, Illinois, United States
View Trial DetailsNCT04781049
Benign Prostatic Hyperplasia, Benign Prostatic Hypertrophy
Roma, RM, Italy
View Trial DetailsNCT00427219
Benign Prostatic Hypertrophy, Genital Diseases
Tucson, Arizona, United States
View Trial Details